PRESTIGE BIOPHARMA PTE LTD has a total of 13 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are OSSIANIX INC, INNOVATIVE TARGETING SOLUTIONS INC and BIOREN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 4 | |
#3 | Brazil | 1 | |
#4 | China | 1 | |
#5 | Republic of Korea | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Fermentation | |
#5 | Analysing materials | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ahn Yong Ho | 8 |
#2 | Yoon Ji Yong | 5 |
#3 | Kim Young Min | 5 |
#4 | Kim Won Kyum | 5 |
#5 | Kim Soo Kwang | 5 |
#6 | Son Yong Gyu | 3 |
#7 | Lee Jung Woo | 3 |
#8 | Ahn Kyo Eun | 3 |
#9 | Hwang Eun Ho | 3 |
#10 | Park Jun Yong | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020250204A1 | Novel antibodies specific for cthrc1 and use thereof | |
BR112016007547A2 | ? bicistronic expression vector for antibody expression and method for the production of antibodies using the same? |